Loading company…
Stelvio Oncology, founded in 2017 in San Francisco, is a biotech developing a personalized approach to treating glioblastoma.
Founded in 2017 and based in California, US, Stelvio Oncology is a biotechnology company that develops a personalized approach to treating glioblastoma.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in